This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/01/15 - 1:57:17 PM ET (BATS BZX Real-time Price)
Div Yield: --
TEAR Day's Range
TEAR 52 Week Range
TEAR Business Summary
TearLab Corp. operates as an ophthalmic device company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease.View TEAR key stats
TearLab Corp - TEAR - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates TearLab Corp as a
Sell with a ratings score of D.
Report Snippet: We rate TearLab Corp (TEAR) a Sell.
This is based on the convergence of positive investment measures, which should help this stock outperform the majority
of stocks that we rate. The company's strengths can be seen in multiple areas, such as its solid stock price performance,
growth in earnings per share, revenue growth, notable return on equity and expanding profit margins. Although the company
may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results.